The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc announced that its Green Roads CBD wellness subsidiary has become an official Supporting Sponsor of the Arthritis Foundation, after giving a $120,000 donation to support the organization’s pain management initiative to advance improved quality of life for those living with chronic pain.
The company said Green Roads is also launching an Arthritis Pain Relief Roll-On product nationwide to further serve this community and provide relief to those currently battling arthritis pains.
“As a company, Green Roads is 100% focused on helping people feel better today than they did yesterday,” Valens CEO Tyler Robson said in a statement.
READ: The Valens Company says it is on path towards being EBITDA positive by fiscal fourth quarter this year
“Supporting the Arthritis Foundation’s long-term work and creating products that can provide benefits to millions of arthritis patients align perfectly with our mission and our purpose,” Robson added.
The Arthritis Pain Relief Roll-On is an over-the-counter (OTC) product formulated by Green Roads’ in-house team of pharmacists with ingredients known to relieve arthritic pain, such as menthol and camphor, plus 1,500 milligrams of hemp-derived CBD and other supportive botanicals.
Valens noted that Green Roads’ support of this initiative is expected to help the Arthritis Foundation establish new tools and resources for pain interferences while expanding a community of support.
It added that the new products are now available for purchase on GreenRoads.com and in select retail locations across the country.
The Valens Company (TSX:VLNS, OTCQX:VLNCF) is a leading manufacturer of cannabis products that provides proprietary cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods.
Contact Sean at sean@proactiveinvestors.com